IPPRA / Grant Monitor

2026-07-07
← Board

DoW Rare Cancers Resource and Community Development Award

HT942526RCRPRCDA · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health ai data science education workforce Science & Technology R&D

Closes
2026-11-18 · 134 d
Award ceiling
Award floor
Program funding
$5,600,000
Expected awards
5
Cost sharing
No
Posted
2026-06-17
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

Funds development of rare-cancer research resources, datasets, communication/dissemination infrastructure, and related mechanistic or therapeutic-enabling resources for rare-cancer research communities.

Funds
data infrastructure
University
direct
social behavioral
minor
physical sciences
minor
engineering
minor
life biomedical
central
computational data
substantial

⚑ Patient Advocate engagement/partnership plan required across the project lifecycle · Community building, dissemination, and sustainability must be addressed · Preliminary data not required

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 80 strong technical depth: substantial; funds data infrastructure
IPPRA 58 good peripheral portfolio topic: public_health; signature methods: community engaged; social/behavioral work is minor; funds data/survey infrastructure; biomedical core — IPPRA health lane is communication/crisis/policy (capped)
Tom Love Innovation Hub 15 none deep-tech content; no commercialization signal

Description

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Research supporting this funding opportunity should fill one of the following major gaps: Lack of research and clinical resources, including patient tissues, cell and tumor models.

Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings.

Lack of infrastructure for sharing data and other resources.

Lack of therapeutics and mechanistic research to inform treatment development.

Distinctive Features: Documentation of plans for engagement and partnerships with Patient Advocates throughout the life cycle of the research study from development of the research question through execution of the study.

Community building and enhancement are key components.

A description of the dissemination and sustainability of the platform for scientific and/or clinical and patient community is required.

Preliminary data are not required but may be included to address feasibility.

Apply

View on Grants.gov → CONTACT: JoAnn Martin Grantor <help@eBRAP.org>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →

Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING